Guardian Bio
ActiveDendritic cell-based platform for cancer therapy
What it does
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.
Its site says now · captured 2026-08-23
Guardian Bio
Reinventing Dendritic Cell Therapy for Solid Tumors
Next to it in Healthcare and bio · dendritic cell cancer immunotherapy
- Sift BiosciencesPlug and Play PnP 2025
Supercharging existing cancer therapies.
- Adventris PharmaceuticalsY Combinator W23
Adventris makes cancer vaccines
- Kopra BioY Combinator S24
Genetically engineered viruses that teach your immune system to kill…
- Kernal BiologicsY Combinator S20
Kernal is creating mRNA 2.0 therapies that work in specific cells
- WittGenPlug and Play PnP 2025
GenAI virtual patients to ensure clinical success
- FREZENT Biological SolutionsSOSV SOSV IndieBio NY 07
Changing the prognosis for patients with advanced stage cancer
- Yemaachi BiotechnologyY Combinator S21
Diversifying precision cancer diagnostics and treatments
- Nuntius TherapeuticsY Combinator W21
Cell-specific genetic medicines